Integrity and efficiency: AbbVie’s journey of building an integrated nonregulated bioanalytical laboratory: Supplementary materials

While bioanalytical outsourcing is widely adopted in the pharmaceutical industry, AbbVie is one of the few large biopharmaceutical companies having an internal bioanalytical unit to support nearly all its drug metabolism and pharmacokinetic studies. This article highlights our experience and perspective in building an integrated and centralized laboratory to provide early discovery and preclinical-stage bioanalytical supportwith high operational efficiency, cost–effectiveness and data integrity. The advantages of in-house nonregulated bioanalytical support include better control of data quality, faster turnaround times, realtime knowledge sharing and troubleshooting, and lower near- and long-term costs. The success of an inhouse model depends upon a comprehensively optimized and streamlined workflow, fueled by continuous improvements and implementation of innovative technologies.